Ocean Biomedical Inc (OCEA)

Dec 20, 2024

Ocean Biomedical stock hits 52-week low at $0.51 - Investing.com

Dec 20, 2024

Dec 17, 2024

Ocean Biomedical appoints new auditing firm - Investing.com

Dec 17, 2024

Dec 17, 2024

Ocean Biomedical appoints new auditing firm By Investing.com - Investing.com UK

Dec 17, 2024

Dec 12, 2024

Biotech Stocks Are Tumbling — But The Top 5 Are Standouts - Investor's Business Daily

Dec 12, 2024

Dec 12, 2024

Ocean Biomedical faces Nasdaq delisting over market value - Investing.com

Dec 12, 2024

Dec 10, 2024

Ocean Biomedical faces Nasdaq delisting over share price - Investing.com

Dec 10, 2024

Dec 10, 2024

Ocean Biomedical faces Nasdaq delisting over share price By Investing.com - Investing.com Canada

Dec 10, 2024

Dec 06, 2024

Ocean Biomedical dismisses Deloitte as certifying accountant - Investing.com

Dec 06, 2024

Dec 06, 2024

Ocean Biomedical dismisses Deloitte as certifying accountant By Investing.com - Investing.com Nigeria

Dec 06, 2024

Dec 02, 2024

Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Down 16.6% in November - Defense World

Dec 02, 2024

Nov 26, 2024

Bolt Biotherapeutics (BOLT) Stock Surges Amid Biotech Sector Mov - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

Ocean Biomedical faces Nasdaq delisting - Providence Business News

Nov 26, 2024

Nov 25, 2024

Ocean Biomedical Inc Com (OCEA) reports earnings - Quartzy

Nov 25, 2024

Nov 22, 2024

Ocean Biomedical, Inc. Announces Receipt of Notice from - GlobeNewswire

Nov 22, 2024

Nov 22, 2024

Compugen (CGEN) Stock Dips Amidst Biotech Sector Movements - GuruFocus.com

Nov 22, 2024

Nov 22, 2024

Ocean Biomedical Faces Nasdaq Delisting Threat - TipRanks

Nov 22, 2024

Nov 22, 2024

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q - The Manila Times

Nov 22, 2024

Nov 22, 2024

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q - GlobeNewswire Inc.

Nov 22, 2024

Nov 22, 2024

Capricor Therapeutics (CAPR) Stock Surges Amid Positive Analyst Ratings - GuruFocus.com

Nov 22, 2024

Nov 22, 2024

CO2 Energy Transition Corp. Announces Closing of Previously Announced IPO and Full Exercise of Over-allotment - EIN News

Nov 22, 2024

Nov 20, 2024

BW LPG takes delivery of vessel BW Capella - MSN

Nov 20, 2024

Nov 20, 2024

Class Action Lawsuit Against Bumble Inc. (NASDAQ:BMBL) - MSN

Nov 20, 2024

Nov 04, 2024

BeyondSpring (BYSI) Stock Drops Amid Biotech Sector Volatility - GuruFocus.com

Nov 04, 2024

Nov 01, 2024

Capricor Therapeutics (CAPR) Faces 5% Drop Amid Industry Slump - GuruFocus.com

Nov 01, 2024

Nov 01, 2024

Curis (CRIS) Stock Plummets Over 5% Amid Lack of Institutional R - GuruFocus.com

Nov 01, 2024

Oct 30, 2024

Ocean Biomedical appoints interim CEO amid executive shift - Investing.com India

Oct 30, 2024

Oct 29, 2024

Ocean Biomedical appoints interim CEO amid executive shift By Investing.com - Investing.com South Africa

Oct 29, 2024

Oct 23, 2024

Ocean Biomedical receives Nasdaq’s delisting letter - MSN

Oct 23, 2024

Oct 23, 2024

Conavi Medical Corp. Engages ICP Securities Inc. for Automated Market Making Services - The Manila Times

Oct 23, 2024

Oct 22, 2024

Ocean Biomedical, Inc. Announces Receipt of Nasdaq Staff Determination Letter - GlobeNewswire

Oct 22, 2024

Oct 22, 2024

Taipei showcases cutting-edge medical devices & diagnostics at Medica 2024 - healthcare-in-europe.com

Oct 22, 2024

Oct 17, 2024

Ocean Biomedical secures 22% Virion stake with $9 million deal - Investing.com India

Oct 17, 2024

Oct 17, 2024

Ocean Biomedical secures 22% Virion stake with $9 million deal By Investing.com - Investing.com South Africa

Oct 17, 2024

Oct 15, 2024

Molecure inks $32 million deal with Ocean Biomedical for cancer therapy - Investing.com India

Oct 15, 2024

Oct 15, 2024

Molecure (WSE: MOC) and Nasdaq-listed biotechnology company Ocean Biomedical (NASDAQ: OCEA) sign an exclusive licensing agreement for the development and commercialization of selective YKL-40 inhibitors. - The Manila Times

Oct 15, 2024

Oct 15, 2024

Molecure (WSE: MOC) and Nasdaq-listed biotechnology company - GlobeNewswire

Oct 15, 2024

Oct 15, 2024

Molecure S.A. and Ocean Biomedical Inc. Sign an Exclusive Licensing Agreement for the Development and Commercialization of Selective YKL-40 inhibitors - Marketscreener.com

Oct 15, 2024

Oct 15, 2024

CAE Inc. (CAE): An Undervalued Foreign Stock to Buy According to Analysts - Yahoo Finance UK

Oct 15, 2024

Oct 14, 2024

ArrowMark Financial Corp. Releases Month End Estimated Net Asset Value as of September 2024 - EIN News

Oct 14, 2024

Oct 14, 2024

Casella Waste Systems, Inc. to Host Conference Call on Its Third Quarter 2024 Results - EIN News

Oct 14, 2024

Oct 14, 2024

Kaltura to Announce Financial Results for Third Quarter 2024 on Wednesday, November 6, 2024 - EIN News

Oct 14, 2024

Oct 14, 2024

Shareholders of Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your - EIN News

Oct 14, 2024

Oct 14, 2024

Class Action Filed Against Verve Therapeutics, Inc. (VERV) Seeking Recovery for Investors – Contact Levi & - EIN News

Oct 14, 2024

Oct 14, 2024

DOMINO’S PIZZA, INC. (NYSE: DPZ) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Domino’s Pizza, Inc. Investors - EIN News

Oct 14, 2024

Oct 10, 2024

BioPhotonics Conference 2024 - Photonics Spectra

Oct 10, 2024